Top 10 Companies in the Pharmaceutical Grade Maltitol Market (2026): Market Leaders Powering Global Pharma

MARKET INSIGHTS

The global pharmaceutical grade maltitol market was valued at USD 167 million in 2024. The market is projected to grow from USD 180 million in 2025 to USD 254 million by 2032, exhibiting a CAGR of 6.2% during the forecast period (2025–2034).

Pharmaceutical grade maltitol (PGM) is a sugar alcohol derived from maltose through hydrogenation. This white crystalline powder serves as a low‑calorie sweetener and excipient in pharmaceutical formulations due to its high solubility, stability, and compatibility with active ingredients. Its applications span oral suspensions, syrups, coating agents, and other drug delivery systems where controlled sweetness and texture modification are required.

Pharmaceutical Grade Maltitol Market – View in Detailed Research Report

1️⃣ 1. Cargill

Headquarters: Chicago, Illinois, USA
Key Offering: Pharmaceutical grade maltitol for excipient and sweetener applications

Cargill has leveraged its extensive agricultural supply chain to secure a leading position in the pharmaceutical excipient market. By integrating advanced hydrogenation and purification technologies, the company delivers high‑purity maltitol that meets stringent pharmacopeia standards, enabling its use in oral suspensions, chewable tablets, and coating formulations.

Sustainability & Growth Initiatives:

• Investments in energy‑efficient hydrogenation processes to reduce carbon footprint
• Partnerships with sustainable starch suppliers to secure long‑term raw material supply
• Development of low‑lactose maltitol variants for pediatric formulations
• Expansion of production capacity in Asia‑Pacific to meet rising demand

2️⃣ 2. Roquette Pharma

Headquarters: Paris, France
Key Offering: Pharmaceutical grade maltitol for excipients, sweeteners, and taste‑masking solutions

Roquette Pharma has built a reputation for delivering high‑purity maltitol with exceptional solubility and low hygroscopicity. The company’s focus on continuous process optimization has enabled consistent quality, making it a preferred supplier for manufacturers of chewable tablets and liquid suspensions.

Sustainability & Growth Initiatives:

• Implementation of circular economy practices in raw material sourcing
• Research into biodegradable excipient formulations
• Collaboration with pharmaceutical partners to develop glucose‑controlled release systems
• Investment in digital traceability for supply chain transparency

3️⃣ 3. Zhejiang Huakang Pharmaceutical

Headquarters: Hangzhou, China
Key Offering: High‑purity maltitol for excipient, sweetener, and coating applications

With a market share exceeding 18% in Asia‑Pacific, Zhejiang Huakang has capitalized on China’s growing pharmaceutical industry. The company’s vertically integrated production facilities ensure rapid scale‑up and cost competitiveness, positioning it as a key supplier for pediatric and geriatric formulations.

Sustainability & Growth Initiatives:

• Adoption of renewable energy sources for manufacturing plants
• Participation in government initiatives to promote domestic excipient production
• Development of low‑lactose maltitol for allergy‑friendly products
• Expansion of R&D into vaccine stabilizers and microneedle matrices

4️⃣ 4. Hylen Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Pharmaceutical grade maltitol for excipients and sweeteners

Hylen has emerged as a cost‑effective producer of maltitol, leveraging local starch resources and efficient hydrogenation processes. The company focuses on delivering high‑purity maltitol to manufacturers of oral suspensions and chewable tablets, with an emphasis on quality compliance.

Sustainability & Growth Initiatives:

• Implementation of water‑recycling systems in production lines
• Use of biodegradable packaging for bulk maltitol shipments
• Partnerships with local farmers to secure sustainable starch supply
• Investment in process automation to improve yield and reduce waste

5️⃣ 5. Mitsubishi Shoji Foodtech

Headquarters: Tokyo, Japan
Key Offering: Maltitol for tablet coating and taste‑masking applications

Mitsubishi Shoji Foodtech has positioned itself as a specialist in maltitol‑based coating formulations. By collaborating with Japanese pharmaceutical companies, the firm delivers high‑performance coatings that mask bitter APIs while maintaining tablet integrity and enhancing patient compliance.

Sustainability & Growth Initiatives:

• Development of eco‑friendly coating agents with reduced VOC emissions
• Collaboration with academia on smart excipient formulations
• Investment in high‑purity maltitol production to support extended‑release tablets
• Participation in Japan’s green chemistry initiatives

6️⃣ 6. Shandong Lvjian Biotechnology

Headquarters: Jinan, China
Key Offering: Pharmaceutical grade maltitol for excipients, sweeteners, and stabilizers

Shandong Lvjian has focused on producing high‑purity maltitol for injectable and oral formulations. The company’s state‑of‑the‑art purification processes meet stringent pharmacopeia standards, enabling its use in sensitive drug delivery systems.

Sustainability & Growth Initiatives:

• Implementation of energy‑saving hydrogenation reactors
• Adoption of green chemistry principles in raw material processing
• Collaboration with research institutions on vaccine stabilizers
• Expansion of production capacity to serve emerging markets

7️⃣ 7. Futaste

Headquarters: Shanghai, China
Key Offering: High‑purity maltitol for injectable and oral formulations

Futaste has invested heavily in purification technologies to deliver maltitol that meets the highest pharmaceutical standards. The company’s focus on injectable applications has opened new market segments beyond traditional oral products.

Sustainability & Growth Initiatives:

• Development of low‑lactose maltitol for allergy‑sensitive patients
• Implementation of closed‑loop water recycling in manufacturing
• Collaboration with global pharma partners for vaccine stabilizers
• Investment in digital quality management systems

8️⃣ 8. Tereos

Headquarters: Paris, France
Key Offering: Pharmaceutical grade maltitol for excipients and sweeteners

Tereos combines its agricultural expertise with advanced chemical processing to supply high‑purity maltitol. The company’s focus on sustainability and quality has earned it a strong reputation among manufacturers of oral suspensions and chewable tablets.

Sustainability & Growth Initiatives:

• Use of renewable energy sources in production facilities
• Partnerships with organic starch producers
• Investment in biodegradable packaging solutions
• Research into low‑glycemic maltitol variants

9️⃣ 9. SPI Pharma

Headquarters: Chicago, Illinois, USA
Key Offering: Pharmaceutical grade maltitol for excipients and sweeteners

SPI Pharma has strengthened its position through strategic acquisitions of specialty chemical firms, expanding its portfolio of high‑purity maltitol solutions. The company serves a diverse customer base, including contract manufacturers and research institutions.

Sustainability & Growth Initiatives:

• Implementation of ISO 14001 environmental management systems
• Investment in energy‑efficient hydrogenation reactors
• Collaboration with universities on advanced excipient research
• Development of low‑lactose maltitol for pediatric formulations

🔟 10. Ingredion

Headquarters: Chicago, Illinois, USA
Key Offering: Pharmaceutical grade maltitol for excipients, sweeteners, and stabilizers

Ingredion’s extensive R&D capabilities and global distribution network enable it to deliver high‑quality maltitol to pharmaceutical manufacturers worldwide. The company focuses on innovation in taste‑masking and low‑calorie sweetener applications.

Sustainability & Growth Initiatives:

• Use of renewable energy in production plants
• Partnerships with sustainable starch suppliers
• Investment in closed‑loop water recycling systems
• Development of eco‑friendly packaging for bulk maltitol

Download FREE Sample Report

Get Full Report

Outlook

The global pharmaceutical grade maltitol market is expected to maintain a steady growth trajectory, driven by increasing demand for sugar‑free pharmaceutical formulations and the rising prevalence of diabetes. North America is projected to lead consumption, while Asia‑Pacific is anticipated to capture the largest share of production capacity. Regulatory approvals from the FDA and EFSA, coupled with the growing clean‑label movement, are expected to reinforce market expansion through 2034.

Future Trends

Emerging trends in the pharmaceutical grade maltitol market include the development of next‑generation drug delivery systems such as biodegradable microneedle arrays and orodispersible films, where maltitol’s moisture‑retention and glass‑transition properties provide unique advantages. The convergence of pharmaceuticals and nutraceuticals is creating opportunities for synbiotic formulations that combine maltitol with probiotics to enhance gut health. Additionally, the adoption of digital traceability and closed‑loop manufacturing processes will drive cost efficiencies and support sustainable production.